NeuroPace (NPCE) EPS (Weighted Average and Diluted) (2020 - 2026)
NeuroPace's quarterly EPS (Weighted Average and Diluted) came in at -$0.2 in Q1 2026, up 4.76% year-on-year from -$0.19 in Q1 2025, and down 150.0% quarter-over-quarter from -$0.08 in Q4 2025.
NeuroPace has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$0.2 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 4.76% year-over-year to -$0.2; the trailing twelve-month figure through Mar 2026 stood at -$0.65 (up 21.69% YoY), and the FY2025 full-year result was -$0.66, up 29.03% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.2, down from -$0.08 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.08 in Q4 2025, with the low at -$0.52 in Q2 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.29, with a median of -$0.26 recorded in 2024.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 98.56% in 2022, while the deepest fall reached 41.18% in 2022.
- Tracing NPCE's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.44 in 2022, then soared by 50.0% to -$0.22 in 2023, then grew by 22.73% to -$0.17 in 2024, then soared by 52.94% to -$0.08 in 2025, then sank by 150.0% to -$0.2 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.2 (Q1 2026), -$0.08 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.11 |
| Jun 30, 2025 | -0.26 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.19 |
| Jun 30, 2024 | -0.26 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -0.28 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | -0.44 |
| Sep 30, 2022 | -0.48 |
| Jun 30, 2022 | -0.52 |
| Mar 31, 2022 | -0.47 |
| Dec 31, 2021 | -0.36 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.48 |
| Mar 31, 2021 | -32.73 |
| Dec 31, 2020 | -21.83 |
| Sep 30, 2020 | -19.26 |
| Jun 30, 2020 | -43.44 |
| Mar 31, 2020 | -33.32 |